SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ewenstein B. M.)
 

Search: WFRF:(Ewenstein B. M.) > Comparative pharmac...

  • Björkman, SvenUppsala universitet,Institutionen för farmaceutisk biovetenskap,PKPD (author)

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults : the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • Elsevier BV,2010
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-123012
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-123012URI
  • https://doi.org/10.1111/j.1538-7836.2010.03757.xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: Dose tailoring of coagulation factors requires reliably estimated and reproducible pharmacokinetics (PK) in the individual patient. OBJECTIVES: To investigate the contribution of both biological and methodological factors to the observed variability of factor VIII (FVIII) PK, with the focus on differences between children and adults, and to examine the implications for dosing. PATIENTS: Data from 52 1-6-year-old and 100 10-65-year-old patients with hemophilia A (FVIII < or = 2 IU dL(-1)) in three clinical studies were included. RESULTS: In vivo recovery was lower, weight-adjusted clearance was higher and FVIII half-life was on average shorter in children than in adults. However, a reduced blood sampling schedule for children was estimated to account for up to one half of the total observed differences. Intrapatient variance in PK was smaller than interpatient variance in 10-65-year-olds. Age and ratio of actual to ideal weight only showed weak relationships with PK parameters. Variance in PK caused large variance in the calculated dose required to maintain a target FVIII trough level during prophylactic treatment. CONCLUSION: Differences in blood sampling schedules should be taken into account when results from different PK studies are compared. However, even with this consideration, PK cannot be predicted from observable patient characteristics but must be determined for the individual. Because the influence of reducing the blood sampling was minor in comparison to the true variance between patients, a reduced blood sampling protocol can be used. Low intrapatient variability supports the use of PK measurements for dose tailoring of FVIII.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Blanchette, V. S. (author)
  • Fischer, K. (author)
  • Oh, M. (author)
  • Spotts, G. (author)
  • Schroth, P. (author)
  • Fritsch, S. (author)
  • Patrone, L. (author)
  • Ewenstein, B. M. (author)
  • Collins, P. W. (author)
  • Uppsala universitetInstitutionen för farmaceutisk biovetenskap (creator_code:org_t)

Related titles

  • In:Journal of Thrombosis and Haemostasis: Elsevier BV8:4, s. 730-7361538-79331538-7836

Internet link

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Björkman, Sven
Blanchette, V. S ...
Fischer, K.
Oh, M.
Spotts, G.
Schroth, P.
show more...
Fritsch, S.
Patrone, L.
Ewenstein, B. M.
Collins, P. W.
show less...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmaceutical S ...
Articles in the publication
Journal of Throm ...
By the university
Uppsala University

Search outside SwePub

Wikipedia about the author:
Sven_Björkman
Björkman, Sven
en

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view